Drug Profile
ZY I1
Alternative Names: ZYI1Latest Information Update: 11 Sep 2015
Price :
$50
*
At a glance
- Originator Zydus-Cadila
- Developer Zydus Cadila
- Class Analgesics; Anti-inflammatories
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 16 Apr 2010 Phase-II clinical trials in Pain in India (unspecified route)
- 08 Dec 2006 Phase-I clinical trials in Pain in India (unspecified route)
- 25 Jan 2006 Preclinical trials in Pain in India (unspecified route)